A further analysis of VEGFA genetics in CLL subgroups defined by different clinical and molecular parameters assessed an association between the VEGFA ACG+/+ genotype with a molecular marker of aggressive leukaemia: the unmutated status of the immunoglobulin variable gene segments (IgVH). This evidence concerns the gene VEGFA and B-cell chronic lymphocytic leukemia.